Industry Bulletins | December 21, 2022
Accenture Invests In BehaVR To Help Expand Access To Behavioral Health Care Using Virtual Reality; BehaVR Acquires OxfordVR
Accenture, through its Accenture Ventures subsidiary, invested in BehaVR, which provides virtual reality (VR) digital wellness and digital therapeutics experiences. On the same day, BehaVR announced a merger with OxfordVR, a spin-out of Oxford University and a leader in science-based virtual reality treatments for serious mental illnesses. The newly combined entity will offer comprehensive, cross-acuity, VR-based therapeutic interventions for mental health. The financial terms of these deals were not disclosed.
OxfordVR, whose gameChange product was recently granted a FDA Breakthrough Device designation, will treat patients using automated cognitive-behavioral VR therapy. These therapies can be delivered . . .